Document Detail

Mycobacterium tuberculosis lacking all mycolic acid cyclopropanation is viable but highly attenuated and hyperinflammatory in mice.
MedLine Citation:
PMID:  22431648     Owner:  NLM     Status:  MEDLINE    
Mycolic acids, the major lipid of the Mycobacterium tuberculosis cell wall, are modified by cyclopropane rings, methyl branches, and oxygenation through the action of eight S-adenosylmethionine (SAM)-dependent mycolic acid methyltransferases (MAMTs), encoded at four genetic loci. Mycolic acid modification has been shown to be important for M. tuberculosis pathogenesis, in part through effects on the inflammatory activity of trehalose dimycolate (cord factor). Studies using the MAMT inhibitor dioctylamine have suggested that the MAMT enzyme class is essential for M. tuberculosis viability. However, it is unknown whether a cyclopropane-deficient strain of M. tuberculosis would be viable and what the effect of cyclopropane deficiency on virulence would be. We addressed these questions by creating and characterizing M. tuberculosis strains lacking all functional MAMTs. Our results show that M. tuberculosis is viable either without cyclopropanation or without cyclopropanation and any oxygenated mycolates. Characterization of these strains revealed that MAMTs are required for acid fastness and resistance to detergent stress. Complete lack of cyclopropanation confers severe attenuation during the first week after aerosol infection of the mouse, whereas complete loss of MAMTs confers attenuation in the second week of infection. Characterization of immune responses to the cyclopropane- and MAMT-deficient strains indicated that the net effect of mycolate cyclopropanation is to dampen host immunity. Taken together, our findings establish the immunomodulatory function of the mycolic acid modification pathway in pathogenesis and buttress this enzyme class as an attractive target for antimycobacterial drug development.
Daniel Barkan; Dorsaf Hedhli; Han-Guang Yan; Kris Huygen; Michael S Glickman
Related Documents :
23803388 - When the threat comes from inside the body: a neuroscience based learning perspective o...
23171498 - Thought disorder in the meta-structure of psychopathology.
24022508 - Expression of gabaa α2-, β1- and ɛ-receptors are altered significantly in the latera...
23017488 - Burns and mental disorder.
21991268 - Broadening the diagnosis of bipolar disorder: benefits vs. risks.
1393308 - Hysterical conversion. ii: a critique.
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't     Date:  2012-03-19
Journal Detail:
Title:  Infection and immunity     Volume:  80     ISSN:  1098-5522     ISO Abbreviation:  Infect. Immun.     Publication Date:  2012 Jun 
Date Detail:
Created Date:  2012-05-14     Completed Date:  2012-07-17     Revised Date:  2013-11-01    
Medline Journal Info:
Nlm Unique ID:  0246127     Medline TA:  Infect Immun     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1958-68     Citation Subset:  IM    
Division of Infectious Diseases, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Bacterial Proteins / genetics,  metabolism
Cyclopropanes / metabolism*
Cytokines / metabolism
Gene Expression Regulation, Bacterial / physiology
Inflammation / microbiology*,  pathology
Methyltransferases / genetics,  metabolism
Mice, Inbred C57BL
Mycobacterium tuberculosis / genetics,  metabolism*
Mycolic Acids / metabolism*
Reverse Transcriptase Polymerase Chain Reaction
Grant Support
Reg. No./Substance:
0/Bacterial Proteins; 0/Cyclopropanes; 0/Cytokines; 0/Mycolic Acids; 99TB643425/cyclopropane; EC 2.1.1.-/Methyltransferases

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Multigene families in Trypanosoma cruzi and their role in infectivity.
Next Document:  The recall response induced by genital challenge with Chlamydia muridarum protects the oviduct from ...